Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction
NCT ID: NCT05049070
Last Updated: 2023-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
349 participants
INTERVENTIONAL
2021-09-15
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Evaluate Effectiveness of Digital Refraction
NCT03502863
Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children
NCT03447171
Study of a Hand-held Device Plus Mobile App Versus Standard Eye Care Devices in Measuring Refractive Error of the Eye
NCT03929588
Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions
NCT06883032
Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population
NCT03119675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Study will be conducted in 2 parts; Part 1 and Part 2.
Approximately 59 participants will be enrolled In Part 1. Part 1 participants will have a GoEyes refraction test in clinic on two separate days and will also have a standard of care refraction test performed by a health care provider and best corrected visual acuity assessments.
Approximately 349 participants will be enrolled in Part 2. Part 2 participants will self administer the GoEyes test at home on 2 separate days and will also have in clinic standard of care refraction test performed by a health care provider and best corrected visual acuity assessments.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GoEyes
GoEyes Self administered refraction test + Standard of care refraction test
Mobile medical application to self administer a subjective refraction test
GoEyes is a software as a medical device and mobile medical application, which is downloaded to a smartphone and is a self-administered subjective refraction test that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals
Standard of care refraction test
Standard of care subjective manifest refraction test performed by a healthcare professional
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile medical application to self administer a subjective refraction test
GoEyes is a software as a medical device and mobile medical application, which is downloaded to a smartphone and is a self-administered subjective refraction test that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals
Standard of care refraction test
Standard of care subjective manifest refraction test performed by a healthcare professional
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Normal color vision
3. Able to use both hands at the same time and to hear, understand and verbally respond to audio instructions
4. Have single vision lenses only
5. Able to provide informed consent -
Exclusion Criteria
2. Have a history of permanent vison loss
3. Have a neurological condition affecting vision
4. Have worn glasses since age 6 or younger
5. Have a prism in their prescription
6. Use Rigid gas permeable lenses or OrthoK lenses
7. Have had laser refractive surgery or any other eye surgery
8. Use prescription eye drops -
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
1800 Contacts, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Matrix Clinical Research
Beverly Hills, California, United States
North Bay Eye Associates
Petaluma, California, United States
Empire Clinical Research
Pomona, California, United States
Segal Drug Trials
Delray Beach, Florida, United States
Butchertown Clinical Trials
Louisville, Kentucky, United States
Tauber Eye Center
Kansas City, Missouri, United States
IMA Research
Las Vegas, Nevada, United States
Core, Inc Vita Eye Clinic
Shelby, North Carolina, United States
Athens Eye Care
Athens, Ohio, United States
Optimed Research
Marysville, Ohio, United States
Total Eye Care
Memphis, Tennessee, United States
Wagner Macula & Retina
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Brendon Quarnberg
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QAD-079
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.